Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study.
Human research record. Translational stroke research, 2025.
- Human
- 2025
Authorship
Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.
Source: the abstract of PMID 40325343. Checked Verification: Evidence verified by machine against declared source
This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.
Evidence verified by machine against declared source
Key facts
- Design
- Not reported
- System
- Human
- Scale
- Not published. Nothing is shown here and nothing is substituted for it.
- Comparator
- None reported
- Journal
- Translational stroke research
- Year
- 2025
- PMID
- 40325343
- Verification
- Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
- Full-text availability
- Abstract only
Technical summary
Research question
The secondary objectives were to determine the efficacy of Cerebrolysin as compared to the control group in reducing mortality rates (by 3 months) and the risk of ICH (safety outcomes), improving neurological outcome assessed using NIHSS (at 1 day and 7 day), mRS at 7 days and 30 days, proportion of patients with mRS 0–1 at 90 days, and improving activities of daily living (assessed using BI) at days 30 and 90.
Not reported in the declared source: Methods, Key findings. Not published in this record: Study design, Participants or experimental system, Study scale, Intervention or exposure, Comparator, Outcomes examined, Key findings.
Limitations and uncertainty
Not published. Nothing is shown here and nothing is substituted for it.
Cite
Cite the study
Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study.
Staszewski J, Dębiec A, Strilciuc S et al. Translational stroke research. 2025. PMID 40325343
The study and its abstract belong to their authors and publisher. Cite them for anything the study found.
Report an error
If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.
The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.
The report form runs in the interactive page. Open this record with scripts enabled to send a report.
Corrections on this record
No correction has been recorded for this record.
Method sheet
No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.